An investment consortium comprised of investors Adage Capital Management, Deerfield Management, EcoR1 Capital Fund and Jennison Associates have infused $35 million into OvaScience (OTC: OVSC). Leerink Swann served as the lead placement agent for the financing. OvaScience, a life sciences company focused on developing treatments for infertility, will use the funds to support development and commercialization of its treatments and for other general corporate purposes. The Boston-based company has completed multiple rounds of financing, including a $24 million PIPE round this past January.
